Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues SHIM Q1 2026 Earnings WiderthanExpected Loss Drags Shares Lower POLA Q1 2026 Earnings Net Loss of 005 per Share Amid Limited Disclosure PLMR Q1 2026 Earnings EPS Surpasses Estimates by 301 Amid Modest Stock Pullback AVGO Q1 2026 Earnings Narrow EPS Miss Amid Modest Market Response ANAB Q1 2026 Earnings Significant Earnings Miss Amid PreRevenue Stage